[1] Gnecchi M, Zhang Z, Ni A, et al. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res. 2008;103(11): 1204-1219.
[2] 钟华,余敏斌.原发性闭角型青光眼流行病学研究进展[J].眼科学报,2007,23(3):186-192.
[3] 汪俊,崔巍.我国原发性青光眼流行病学研究进展[J].国际眼科杂志,2012,12(4):667-670.
[4] 杨强,郭文毅.原发性闭角型青光眼的流行病学[J].中国眼耳鼻喉科杂志,2008,8(5):334-335.
[5] 张洁,易玉珍.正常人眼小梁网增龄性改变与中青年原发性开角型青光眼小梁网超微病变[J].眼科新进展,1990(2):1-4.
[6] 葛坚,白玉婧.青光眼手术治疗进展[J].实用医院临床杂志,2010, 7(6):8-12.
[7] 王宁利,杨迪亚.同仁医院眼科近年来青光眼基础研究概述[J].眼科,2009,18(1):17-21.
[8] 刘旭阳,陈晓明,贠洪敏.青光眼治疗药物评价[J].世界临床药物, 2007,28(7):404-407,412.
[9] 张秀兰,葛坚,蔡小于,等.两种显微手术方式处理原发性闭角型青光眼的对比研究[J].中华显微外科杂志,2006,29(2): 158-160.
[10] Bailey AK, Sarkisian SR Jr. Complications of tube implants and their management. Curr Opin Ophthalmol. 2014;25(2): 148-153.
[11] Eldaly MA, Bunce C, Elsheikha OZ, et al. Non-penetrating filtration surgery versus trabeculectomy for open-angle glaucoma. Cochrane Database Syst Rev. 2014;2:CD007059.
[12] Chen G1, Li W2, Jiang F1, et al. Ex-PRESS Implantation versus Trabeculectomy in Open-Angle Glaucoma: A Meta-Analysis of Randomized Controlled Clinical Trials. PLoS One. 2014;9(1):e86045.
[13] Sit AJ. Evaluation and adoption of new technology in glaucoma surgery. Am J Ophthalmol. 2014;157(2):263-265.e1.
[14] Hu Y, Tan HB, Wang XM, et al. Bone marrow mesenchymal stem cells protect against retinal ganglion cell loss in aged rats with glaucoma. Clin Interv Aging. 2013;8:1467-1470.
[15] Al-Shamekh S, Goldberg JL. Retinal repair with induced pluripotent stem cells. Transl Res. 2013. in press.
[16] Karl MO. The potential of stem cell research for the treatment of neuronal damage in glaucoma. Cell Tissue Res. 2013; 353(2): 311-325.
[17] Manuguerra-Gagné R1, Boulos PR, Ammar A, et al. Transplantation of mesenchymal stem cells promotes tissue regeneration in a glaucoma model through laser-induced paracrine factor secretion and progenitor cell recruitment. Stem Cells. 2013;31(6):1136-1148.
[18] Wiese C1, Rolletschek A, Kania G, et al. Nestin expression--a property of multi-lineage progenitor cells? Cell Mol Life Sci. 2004;61(19-20):2510-2522.
[19] 张纯.干细胞治疗离青光眼患者有多远?——十年干细胞研究的回顾[J].眼科,2009,18(1):10-13.
[20] Nadri S, Yazdani S, Arefian E, et al. Mesenchymal stem cells from trabecular meshwork become photoreceptor-like cells on amniotic membrane. Neurosci Lett. 2013;541:43-48.
[21] 薛栋,杜成友.Nestin阳性细胞的研究进展[J].国外医学(外科学分册),2005,32(3):193-197.
[22] Jagtap JC, Dawood P, Shah RD, et al. Expression and regulation of prostate apoptosis response-4 (par-4) in human glioma stem cells in drug-induced apoptosis. PLoS One. 2014; 9(2):e88505.
[23] Hatanpaa KJ, Hu T, Vemireddy V, et al. High expression of the stem cell marker nestin is an adverse prognostic factor in WHO grade II-III astrocytomas and oligoastrocytomas. J Neurooncol. 2014;117(1):183-189.
[24] Fu X, Rong Z, Zhu S, et al. Genetic approach to track neural cell fate decisions using human embryonic stem cells. Protein Cell. 2014;5(1):69-79.
[25] Yamahatsu K, Matsuda Y, Ishiwata T, et al. Nestin as a novel therapeutic target for pancreatic cancer via tumor angiogenesis. Int J Oncol. 2012;40(5):1345-1357.
[26] 李永平.我国眼内干细胞研究现状与展望[J].中华眼底病杂志,2007,23(2):83-86 .
[27] Zhong X, Li Y, Peng F, et al. Identification of tumorigenic retinal stem-like cells in human solid retinoblastomas. Int J Cancer. 2007;121(10):2125-2131.
[28] Ormond DR, Shannon C, Oppenheim J, et al. Stem cell therapy and curcumin synergistically enhance recovery from spinal cord injury. PLoS One. 2014;9(2):e88916.
[29] Watanabe M. Adult tissue stem cell therapy for gastrointestinal diseases. J Gastroenterol Hepatol. 2014. in press.
[30] Knight MN, Hankenson KD. Mesenchymal Stem Cells in Bone Regeneration. Adv Wound Care (New Rochelle). 2013;2(6): 306-316.
[31] Ikebe C, Suzuki K. Mesenchymal Stem Cells for Regenerative Therapy: Optimization of Cell Preparation Protocols. Biomed Res Int. 2014;2014:951512.
[32] Raviola G. Schwalbe line's cells: a new cell type in the trabecular meshwork of Macaca mulatta. Invest Ophthalmol Vis Sci. 1982;22(1):45-56.
[33] Acott TS, Samples JR, Bradley JM, et al. Trabecular repopulation by anterior trabecular meshwork cells after laser trabeculoplasty. Am J Ophthalmol. 1989;107(1):1-6.
[34] Nadri S, Yazdani S, Arefian E, et al. Mesenchymal stem cells from trabecular meshwork become photoreceptor-like cells on amniotic membrane. Neurosci Lett. 2013;541:43-48.
[35] Tay CY, Sathiyanathan P, Chu SW, et al. Identification and characterization of mesenchymal stem cells derived from the trabecular meshwork of the human eye. Stem Cells Dev. 2012; 21(9):1381-1390.
[36] Du Y, Yun H, Yang E, et al. Stem cells from trabecular meshwork home to TM tissue in vivo. Invest Ophthalmol Vis Sci. 2013;54(2):1450-1459.
[37] McGowan SL, Edelhauser HF, Pfister RR, et al. Stem cell markers in the human posterior limbus and corneal endothelium of unwounded and wounded corneas. Mol Vis. 2007;13:1984-2000.
[38] Luo W, Li S, Peng B, et al. Embryonic stem cells markers SOX2, OCT4 and Nanog expression and their correlations with epithelial-mesenchymal transition in nasopharyngeal carcinoma. PLoS One. 2013;8(2):e56324.
[39] Fenderson BA, De Miguel MP, Pyle AD, et al. Staining embryonic stem cells using monoclonal antibodies to stage-specific embryonic antigens. Methods Mol Biol. 2006; 325:207-224.
[40] Huang Y, Liang P, Liu D, et al. Telomere regulation in pluripotent stem cells. Protein Cell. 2014. in press.
[41] Singh KP, Kaushik R, Garg V, et al. Expression pattern of pluripotent markers in different embryonic developmental stages of buffalo (Bubalus bubalis) embryos and putative embryonic stem cells generated by parthenogenetic activation. Cell Reprogram. 2012;14(6):530-538.
[42] Tropepe V, Coles BL, Chiasson BJ, et al. Retinal stem cells in the adult mammalian eye. Science. 2000;287(5460): 2032- 2036.
[43] Zimmerman L, Parr B, Lendahl U, et al. Independent regulatory elements in the nestin gene direct transgene expression to neural stem cells or muscle precursors. Neuron. 1994;12(1):11-24.
[44] Zhang M, Song T, Yang L, et al. Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients. J Exp Clin Cancer Res. 2008;27:85.
[45] Lendahl U, Zimmerman LB, McKay RD. CNS stem cells express a new class of intermediate filament protein. Cell. 1990;60(4):585-595.
[46] Li L, Fukunaga-Kalabis M, Herlyn M. Isolation, characterization, and differentiation of human multipotent dermal stem cells. Methods Mol Biol. 2013;989:235-246.
[47] Richter A, Nissen N, Mailänder P, et al. Mammary gland-derived nestin-positive cell populations can be isolated from human male and female donors. Stem Cell Res Ther. 2013;4(4):78.
[48] Tonthat CV, Di Girolamo N. Nestin expression in pterygia: potential role in angiogenesis. Br J Ophthalmol. 2013. in press.
[49] Lendahl U, Zimmerman LB, McKay RD. CNS stem cells express a new class of intermediate filament protein. Cell. 1990;60(4):585-595.
[50] Steinert PM, Chou YH, Prahlad V, et al. A high molecular weight intermediate filament-associated protein in BHK-21 cells is nestin, a type VI intermediate filament protein. Limited co-assembly in vitro to form heteropolymers with type III vimentin and type IV alpha-internexin. J Biol Chem. 1999;274 (14):9881-9980.
[51] Nambirajan A, Sharma MC, Gupta RK, et al. Study of Stem cell marker Nestin and its correlation with Vascular endothelial growth factor and microvascular density in Ependymomas. Neuropathol Appl Neurobiol. 2013. in press.
[52] Matsuda Y, Hagio M, Ishiwata T. Nestin: a novel angiogenesis marker and possible target for tumor angiogenesis. World J Gastroenterol. 2013;19(1):42-48.
[53] Mokrý J, Nemecek S. Angiogenesis of extra- and intraembryonic blood vessels is associated with expression of nestin in endothelial cells. Folia Biol (Praha). 1998;44(5): 155-161.
[54] Carlson BM. Human Embryology and Developmental Biology. Bergen: Saunders. 2003:434.
[55] Abdul Rahman H, Manzor NF, Tan GC, et al. Upregulation of SOX-2, FZD9, Nestin, OCT-4 and FGF-4 expression in human chorion derived-stem cells after angiogenic induction. Med J Malaysia. 2008;63 Suppl A:57-58.
[56] Hwang HS, Cho NH, Maeng YS, et al. Differential expression of nestin in normal and pre-eclamptic human placentas. Acta Obstet Gynecol Scand. 2007;86(8):909-914.
[57] Kim HS, Kang HS, Messam CA, et al. Comparative evaluation of angiogenesis in gastric adenocarcinoma by nestin and CD34. Appl Immunohistochem Mol Morphol. 2002;10(2): 121-127.
[58] El-Helou V, Chabot A, Gosselin H, et al. Cardiac resident nestin(+) cells participate in reparative vascularisation. J Cell Physiol. 2013;228(9):1844-1853.
[59] Hamanaka T, Bill A, Ichinohasama R, et al. Aspects of the development of Schlemm's canal. Exp Eye Res. 1992;55(3): 479-488.
[60] Hamanaka T, Kasahara K, Takemura T. Histopathology of the trabecular meshwork and Schlemm's canal in primary angle-closure glaucoma. Invest Ophthalmol Vis Sci. 2011; 52(12):8849-8861. |